Daily notes / October 15, 2026
United Therapeutics (UTHR) on October 15, 2026: 17 filings in one day
By OQRO's software, from the records of . Published . 2 min read.
The short answer
On October 15, 2026, 17 filings about United Therapeutics (UTHR) entered OQRO's records: 1 insider planned sale, 16 insider sales. That made it one of the busiest listed companies of the day. Each line below links to the filing as it was made with the SEC, the House, the Senate or USAspending.
What was filed about United Therapeutics on October 15, 2026?
17 filings about United Therapeutics carried the date October 15, 2026 in OQRO's records: 1 insider planned sale, 16 insider sales. It was one of the busiest companies of the day by number of filings.
Which filings?
- Officer filed to sell about $4.52M of UTHR stock (PAUL MAHON, Officer), dated Oct 15, 2026: the filing
- CEO sold ~$1.08M of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 14, 2026: the filing
- CEO sold ~$1.04M of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 14, 2026: the filing
- CEO sold ~$606K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 14, 2026: the filing
- CEO sold ~$479K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 14, 2026: the filing
- CEO sold ~$340K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 14, 2026: the filing
- CEO sold ~$283K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 14, 2026: the filing
- CEO sold ~$262K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 14, 2026: the filing
- CEO sold ~$261K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 14, 2026: the filing
- CEO sold ~$217K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 14, 2026: the filing
- CEO sold ~$214K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 14, 2026: the filing
- CEO sold ~$128K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 14, 2026: the filing
- CEO sold ~$85K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 14, 2026: the filing
- CEO sold ~$64K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 14, 2026: the filing
- CEO sold ~$22K of UTHR shares in the open market (Martine A Rothblatt, Chairperson & CEO), dated Oct 14, 2026: the filing
What this does not tell you
Several filings on one day usually share a cause that the filings do not state: a 13F deadline, a trading window after results, a grant date. The United Therapeutics page shows every filing with its source, the price next to it and a dated summary of the last 12 months. This page lists what was filed on one day, with each record linked to its source. A filing does not say why it was made, and this is not investment advice.
Sources
No language model wrote this page: every figure is one of the day's records, linked to its filing. It describes what was filed, not why, and it is not investment advice. How OQRO treats data
Explore the data
More daily notes
- Chernett Jorey reported an Exagen share purchase on Form 4
- Robert Nelsen reported a City Therapeutics open-market purchase
- Control Empresarial reported a Talos Energy share sale on Form 4
- Harel filed a Schedule 13G reporting a 5.2% stake in Elbit Systems
- JP Sailing Capital filed a Schedule 13G on Nextcure
- Norbel Investments filed a Schedule 13G on Papa John's Pizza